• Increase
  • Decrease
  • Normal

Current Size: 100%

Targeted Therapies/Pathway Inhibitors

By Suzanne Herms, 2016

This Guide discusses targeted therapies/pathway inhibitors to B-cell signaling, such as ibrutinib (Imbruvica) and everolimus (RAD001 or Afinitor).

pubtype: 
treatment_guide